Anti-Human Eotaxin (CCL11) (Polyclonal Rabbit) 0 ReviewsSubmit a Review Product Details Catalog Number: 500-P41 Description: Source: Polyclonal Rabbit Preparation: Produced from sera of rabbits pre-immunized with highly pure (>98%) recombinant hEotaxin. Anti-Human Eotaxin specific antibody was purified by affinity chromatography employing immobilized hEotaxin matrix. Immunogen: E.coli derived Recombinant Human Eotaxin (CCL11) (PeproTech catalog# 300-21) Sandwich ELISA: To detect hEotaxin by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech’s Biotinylated Anti-Human Eotaxin (500-P41Bt) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hEotaxin. Western Blot: To detect hEotaxin by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hEotaxin is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions. Note: Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information. Cross Reactivity Cited in References: Human, References SDS CoA Search Product Line Country Of Origin: USA Not for human use. Research Interest Chemotaxis Immune System Wound Healing Recent Citations First Author Thielen, C Title TARC and IL-5 expression correlates with tissue eosinophilia in peripheral T-cell lymphomas. Citation Leukemia Research; 32(9) pg1431-8 PubMed ID 18395252 First Author Blumenthal, R D Title Degranulating eosinophils in human endometriosis. Citation The American Journal of Pathology; 156(5) pg1581-8 PubMed ID 10793070 First Author Teruya-Feldstein, J Title Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia. Citation Blood; 93(8) pg2463-70 PubMed ID 10194423